Full Year 2024 Results Key Financial Results Revenue: US$56.3b (up 3.7% from FY 2023). Net ...
This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.
Micrograph of a diffuse large B cell lymphoma, AbbVie and partner Genmab have FDA ... As a rough comparison, in a similar trial population glofitamab had an overall response rate of 52%, with ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results